Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial - Concepedia

Concepedia

Publication | Open Access

Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial

DOI Full Paper Access

83

Citations

21

References

2025

Year

Nirosen Vijiaratnam, Christine Girges, Grace Auld, Rachel McComish, Alexa King, Simon S. Skene, Steve Hibbert, Alan Wong, Sabina Melander, Rachel Gibson,

Abstract

National Institute for Health and Care Research and Cure Parkinson's.

References

	Year	Citations

Page 1